Apax Partners acquires Healthium MedTech for $350 million2 min read . Updated: 06 Apr 2018, 05:41 AM IST
Apax Partners has acquires close to 100% stake in Healthium MedTech, formerly Sutures India, from shareholders TPG Growth, CX Partners and the founders
Mumbai: Apax Partners Llp has acquired Bengaluru-based medical devices company Healthium MedTech Pvt. Ltd (formerly known as Sutures India).
The London-based private equity (PE) fund has acquired close to 100% stake from existing shareholders, including TPG Growth, CX Partners, and founding shareholders. Though the size of the deal was not disclosed, the transaction is in range of $350 million, said a person aware of the development. TPG Growth owns around 73% in Healthium, while private equity fund CX Partners holds 12%. The rest is held by the promoters.
Mint reported in November that several PE funds, including Bain Capital Lp, Advent International Corp. and Carlyle Group are in a race to acquire surgical equipment maker Sutures India in a deal worth about $425 million.
Healthium, which makes surgical and wound-closure products such as natural and synthetic, absorbable and non-absorbable sutures, surgical needles, staples, tapes and bone wax, competes with firms such as Smith and Nephew Plc, Ethicon Inc. and ConvaTec.
TPG Growth invested in Sutures in 2013 by acquiring a 23% stake from CX Partners and the firm’s promoters for Rs145 crore. Over time, TPG raised its stake and now holds a majority in Sutures.
CX Partners had acquired a 37% stake in Sutures for about Rs200 crore in 2012 by buying out the entire stake held by India Life Sciences Fund.
Founded in 1992, Sutures exports products to 91 countries in Europe, South America, Africa and Asia. It also supplies to over 10,000 hospitals across India.
Backed by Apax, Healthium plans to further deepen its presence in the Indian market and broaden its portfolio of specialty medtech products, said the company statement.
“Healthcare is a key focus area for Apax in India, given secular tailwinds around healthcare spend and government initiatives focused on affordable and universal healthcare," said Shashank Singh, partner at Apax Partners and head of Apax’s India office. The opportunity is to create a medtech platform of scale to deliver a broad portfolio of products in the Indian market, and we are excited to partner with the management team of Healthium to deliver this vision," he added.
The investment in Healthium marks the second investment in the healthcare space by Apax in India, following the investment in Apollo Hospitals. Healthium will be the eighth investment in India for Apax over the past 11 years. Including this transaction, Apax has invested around $2 billion of equity in the country.
“TPG Growth has invested in a significant number of healthcare provider businesses around the world. Thematically, we have always been focused on investing behind companies that offer high-quality products and services with a focus on value," said Matt Hobart, Partner at TPG Growth and leader of the fund’s healthcare practice globally.